U.S. Intravenous Solutions Market Size & Outlook
Related Markets
U.S. intravenous solutions market highlights
- The U.S. intravenous solutions market generated a revenue of USD 4,872.1 million in 2025 and is expected to reach USD 9,840.5 million by 2033.
- The U.S. market is expected to grow at a CAGR of 9.4% from 2026 to 2033.
- In terms of segment, total parenteral nutrition market (tpn) was the largest revenue generating type in 2025.
- Total Parenteral Nutrition Market (TPN) is the most lucrative type segment registering the fastest growth during the forecast period.
Intravenous solutions market data book summary
| Market revenue in 2025 | USD 4,872.1 million |
| Market revenue in 2033 | USD 9,840.5 million |
| Growth rate | 9.4% (CAGR from 2026 to 2033) |
| Largest segment | Total parenteral nutrition market (tpn) |
| Fastest growing segment | Total Parenteral Nutrition Market (TPN) |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Total Parenteral Nutrition Market (TPN), Peripheral Parenteral Nutrition (PPN) |
| Key market players worldwide | Fresenius SE & Co KGaA, Fresenius Kabi, Pfizer Inc, Otsuka Pharmaceutical, Baxter International Inc, B. Braun, JW Life Sciences, CSL Ltd |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.4% of the global intravenous solutions market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. intravenous solutions market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 9,840.5 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intravenous Solutions Market Scope
Intravenous Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| JW Life Sciences | View profile | - | Yangjin, Kyonggi-do, South Korea, Asia | http://jw-lifescience.co.kr/lifescience/ko/main.jsp |
| Fresenius Kabi | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://www.fresenius-kabi-oncology.com/ |
| CSL Ltd | View profile | 32000 | 655 Elizabeth Street, Melbourne, VIC, Australia, 3000 | https://www.csl.com |
| Otsuka Pharmaceutical | View profile | 251-500 | Tokyo, Tokyo, Japan, Asia | https://www.otsuka.co.jp/en/ |
| B. Braun | View profile | 10001+ | Chapeltown, Sheffield, United Kingdom, Europe | https://www.bbraun.co.uk |
| Fresenius SE & Co KGaA | View profile | 193865 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | https://www.fresenius.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
U.S. intravenous solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous solutions market will help companies and investors design strategic landscapes.
Total parenteral nutrition market (tpn) was the largest segment with a revenue share of 72.57% in 2025. Horizon Databook has segmented the U.S. intravenous solutions market based on total parenteral nutrition market (tpn), peripheral parenteral nutrition (ppn) covering the revenue growth of each sub-segment from 2021 to 2033.
The increasing number of disabilities & malnutrition cases due to the rising incidence of chronic medical conditions and the growing geriatric population are among the factors leading to a rise in the demand for intravenous parenteral nutrition products.
The growing incidence of cardiovascular diseases has increased the prevalence of myocardial ischemia-reperfusion injury, propelling the demand for parenteral nutrition in the country for managing these injuries.
Furthermore, according to a study published by the American Society for Parenteral and Enteral Nutrition, including intravenous parenteral nutrition as a patient nutrition support did not increase the chances of bloodstream-related infections and was at par with other nutritional methods.
Reasons to subscribe to U.S. intravenous solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. intravenous solutions market databook
-
Our clientele includes a mix of intravenous solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. intravenous solutions market , including forecasts for subscribers. This country databook contains high-level insights into U.S. intravenous solutions market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. intravenous solutions market size, by type, 2021-2033 (US$M)
U.S. Intravenous Solutions Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
